Clinical Research Directory
Browse clinical research sites, groups, and studies.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Sponsor: Exelixis
Summary
The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors.
Official title: A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
440
Start Date
2025-07-21
Completion Date
2029-06
Last Updated
2026-03-24
Healthy Volunteers
No
Interventions
Zanzalintinib
Administered as specified in the treatment arm.
Everolimus
Administered as specified in the treatment arm.
Locations (66)
Exelixis Clinical Site #43
Birmingham, Alabama, United States
Exelixis Clinical Site #36
Phoenix, Arizona, United States
Exelixis Clinical Site #42
Tucson, Arizona, United States
Exelixis Clinical Site #18
Beverly Hills, California, United States
Exelixis Clinical Site #16
Los Angeles, California, United States
Exelixis Clinical Site #54
Palo Alto, California, United States
Exelixis Clinical Site #12
Santa Monica, California, United States
Exelixis Clinical Site #29
Vallejo, California, United States
Exelixis Clinical Site #19
Washington D.C., District of Columbia, United States
Exelixis Clinical Site #35
Jacksonville, Florida, United States
Exelixis Clinical Site #11
Tampa, Florida, United States
Exelixis Clinical Site #9
Lexington, Kentucky, United States
Exelixis Clinical Site #23
Metairie, Louisiana, United States
Exelixis Clinical Site #8
Boston, Massachusetts, United States
Exelixis Clinical Site #47
Detroit, Michigan, United States
Exelixis Clinical Site #1
Grand Rapids, Michigan, United States
Exelixis Clinical Site #38
Rochester, Minnesota, United States
Exelixis Clinical Site #5
St Louis, Missouri, United States
Exelixis Clinical Site #25
Omaha, Nebraska, United States
Exelixis Clinical Site #14
Albuquerque, New Mexico, United States
Exelixis Clinical Site #59
Buffalo, New York, United States
Exelixis Clinical Site #7
New York, New York, United States
Exelixis Clinical Site #53
Rochester, New York, United States
Exelixis Clinical Site #17
Chapel Hill, North Carolina, United States
Exelixis Clinical Site #6
Durham, North Carolina, United States
Exelixis Clinical Site #57
Fargo, North Dakota, United States
Exelixis Clinical Site #39
Cleveland, Ohio, United States
Exelixis Clinical Site #28
Columbus, Ohio, United States
Exelixis Clinical Site #27
Portland, Oregon, United States
Exelixis Clinical Site #20
Philadelphia, Pennsylvania, United States
Exelixis Clinical Site #21
Pittsburgh, Pennsylvania, United States
Exelixis Clinical Site #24
Knoxville, Tennessee, United States
Exelixis Clinical Site #65
Nashville, Tennessee, United States
Exelixis Clinical Site #10
Dallas, Texas, United States
Exelixis Clinical Site #15
Salt Lake City, Utah, United States
Exelixis Clinical Site #3
Charlottesville, Virginia, United States
Exelixis Clinical Site #13
Fairfax, Virginia, United States
Exelixis Clinical Site #34
Seattle, Washington, United States
Exelixis Clinical Site #31
Milwaukee, Wisconsin, United States
Exelixis Clinical Site #40
Saint Leonards, New South Wales, Australia
Exelixis Clinical Site #51
Clayton, Victoria, Australia
Exelixis Clinical Site #55
Herston, Australia
Exelixis Clinical Site #48
Graz, Austria
Exelixis Clinical Site #61
Ottawa, Canada
Exelixis Clinical Site #49
Toronto, Canada
Exelixis Clinical Site #63
Hong Kong, China
Exelixis Clinical Site 58
Berlin, Germany
Exelixis Clinical Site #52
Tübingen, Germany
Exelixis Clinical Site #45
Katowice, Poland
Exelixis Clinical Site #37
Warsaw, Poland
Exelixis Clinical Site #2
San Juan, Puerto Rico
Exelixis Clinical Site # 4
San Juan, Puerto Rico
Exelixis Clinical Site #30
Seoul, South Korea
Exelixis Clinical Site #46
Seoul, South Korea
Exelixis Clinical Site #32
Seoul, South Korea
Exelixis Clinical Site #41
Seoul, South Korea
Exelixis Clinical Site #26
Seoul, South Korea
Exelixis Clinical Site #56
Madrid, Spain
Exelixis Clinical Site #44
Madrid, Spain
Exelixis Clinical Site #66
Murcia, Spain
Exelixis Clinical Site #60
Santander, Spain
Exelixis Clinical Site #62
Seville, Spain
Exelixis Clinical Site #64
Valencia, Spain
Exelixis Clinical Site #22
London, England, United Kingdom
Exelixis Clinical Site #50
Liverpool, United Kingdom
Exelixis Clinical Site #33
Sheffield, United Kingdom